TCL Archive ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards? November 8, 2002
TCL Archive OMB Revisions Would Kill 16 Center core Grants, Ban New Ones, Slash Noncompeting Funds 10 Percent April 15, 1983
TCL Archive Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting June 20, 1986
TCL Archive In Brief: Less Hazardous Cigarette Only Hope To Reduce Smoking Health Problems, Carter Advisor Says November 25, 1977
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012
